Delivery Order SPE2DB20D3103-SPE2DB24FM0W0

Award Date 12/27/23
Potential Completion Date 12/28/23
Potential Value $62K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in unit doses of 30s, with a ceiling value of $1,895.40 and a completion date of April 11, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,776.58 firm-fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which...
This federal contract award, valued at $26,307.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30, and has an ultimate completion date of February 28, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
This contract, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Telmisartan 40 mg tablets. The ceiling value of the Delivery Order is $17,232.00, and the ultimate completion date is September 1, 2022. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,467.92 firm fixed-price delivery order contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The contract has a completion date of September 21, 2023 and was awarded on September 20, 2023. This delivery order is part of a larger...
This federal contract award, valued at $1,343.25, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,563,226,108 units of Telmisartan 20 mg tablets in 30-count packages, with a completion date of January 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB23FG3ZK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,226.34 contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The contract has a ceiling value of $10,779.60 and an ultimate completion date of December 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle...
This federal contract award, with ID SPE2DX15D2011|SPE2DX24F17QK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units, with a total ceiling value of $3,063.90. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The $7,621.89 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major agency that supplies medical products to the Department of Defense and other federal healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM0W0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets in units of 30, with a ceiling value of $61,689.90 and a completion date of December 28, 2023. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award was made on an unrestricted, full and open competition basis, without any set-aside designation.

Generated 5/13/25, 10:18 AM